Fulcrum Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $13.70 on 03/06/24, while the lowest price for the same duration was marked at $2.86 on 11/19/24.
52-week price history of FULC Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Fulcrum Therapeutics Inc’s current trading price is -71.17% away from its 52-week high, while its distance from the 52-week low is 38.11%. The stock’s price range during this period has spanned from $2.86 to $13.70. In the Healthcare sector, the Fulcrum Therapeutics Inc’s shares surpassed a trading volume of approximately 1.01 million for the day, which was noticeably lower compared to the average daily volume of 9.1.65 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Fulcrum Therapeutics Inc (FULC) has experienced a quarterly decline of -54.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 213.06M and boasts a workforce of 76 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.81, with a change in price of -2.58. Similarly, Fulcrum Therapeutics Inc recorded 1,360,110 in trading volume during the last 100 days, posting a change of -39.51%.
Examining FULC’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for FULC stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
FULC Stock Stochastic Average
Today, Fulcrum Therapeutics Inc’s raw stochastic average for the past 50 days stands at 57.67%, indicating a decline from the raw stochastic average of the last 20 days, which was 89.34%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 68.98% and 51.18% respectively.
FULC Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -41.48%. However, over the last six months, the performance has been stronger by -48.37%. The price of FULC increased 21.91% over the last 30 days. And in the last five days, it has surged by 32.11%.
